Cancer Incidence for Castle Hill, Clason Point & Parkchester, Bronx County, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Males and Females | Males | Females | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
| All Invasive Malignant Tumors | 796.2 | 411.5 | 398.5-424.7 | 385.4 | 474.9 | 453.1-497.5 | 410.8 | 371.9 | 355.7-388.7 |
| Oral cavity and pharynx | 16.6 | 8.8 | 6.9-10.9 | 11.4 | 14.5 | 10.9-18.9 | 5.2 | 4.5 | 2.9-6.7 |
| Esophagus | 6.6 | 3.6 | 2.4-5.0 | 5.0 | 6.8 | 4.3-10.1 | 1.6 | 1.3 | 0.6-2.7 |
| Stomach | 19.8 | 10.7 | 8.6-13.0 | 11.8 | 15.2 | 11.5-19.8 | 8.0 | 7.5 | 5.3-10.2 |
| Colorectal | 66.8 | 35.3 | 31.6-39.4 | 36.0 | 45.7 | 39.0-53.1 | 30.8 | 28.1 | 23.8-33.1 |
| Colon excluding rectum | 46.4 | 24.7 | 21.6-28.2 | 24.0 | 30.5 | 25.1-36.7 | 22.4 | 20.6 | 16.9-24.9 |
| Rectum & rectosigmoid | 20.4 | 10.6 | 8.6-13.0 | 12.0 | 15.2 | 11.4-19.7 | 8.4 | 7.5 | 5.4-10.2 |
| Liver / intrahepatic bile duct | 27.0 | 13.1 | 11.0-15.6 | 20.2 | 23.0 | 18.6-28.1 | 6.8 | 5.8 | 4.0-8.2 |
| Pancreas | 26.0 | 13.6 | 11.3-16.2 | 12.8 | 15.7 | 11.9-20.2 | 13.2 | 11.8 | 9.1-15.2 |
| Larynx | 7.0 | 3.5 | 2.4-5.0 | 5.6 | 6.9 | 4.5-10.1 | 1.4 | 1.2 | 0.5-2.5 |
| Lung and bronchus | 79.8 | 41.3 | 37.2-45.6 | 41.8 | 52.6 | 45.4-60.6 | 38.0 | 33.3 | 28.7-38.5 |
| Melanoma of the skin | 3.2 | 1.6 | 0.9-2.6 | 1.2 | 1.4 | 0.5-3.1 | 2.0 | 1.8 | 0.8-3.3 |
| Female breast | 119.4 | 108.6 | 99.9-117.9 | ||||||
| Cervix uteri | 9.4 | 9.4 | 6.9-12.6 | ||||||
| Corpus uterus and NOS | 37.8 | 32.5 | 28.0-37.6 | ||||||
| Ovary | 13.0 | 12.0 | 9.2-15.4 | ||||||
| Prostate | 112.0 | 128.4 | 117.6-139.9 | ||||||
| Testis | 2.0 | 2.3 | 1.1-4.2 | ||||||
| Urinary bladder (incl. in situ) | 23.0 | 12.6 | 10.4-15.2 | 17.0 | 25.2 | 19.9-31.3 | 6.0 | 5.2 | 3.5-7.5 |
| Kidney and renal pelvis | 25.2 | 12.9 | 10.7-15.4 | 14.4 | 17.9 | 13.9-22.7 | 10.8 | 9.5 | 7.1-12.5 |
| Brain and other central nervous system | 9.8 | 5.4 | 4.0-7.2 | 5.6 | 7.2 | 4.7-10.5 | 4.2 | 3.8 | 2.3-5.9 |
| Thyroid | 27.0 | 14.3 | 11.9-17.0 | 5.8 | 6.7 | 4.4-9.8 | 21.2 | 20.6 | 16.8-25.1 |
| Hodgkin lymphoma | 5.2 | 2.8 | 1.8-4.1 | 2.8 | 3.3 | 1.8-5.6 | 2.4 | 2.3 | 1.2-4.1 |
| Non-Hodgkin lymphomas | 34.8 | 18.1 | 15.5-21.1 | 17.2 | 22.1 | 17.5-27.5 | 17.6 | 15.6 | 12.4-19.3 |
| Myeloma | 22.2 | 11.3 | 9.2-13.6 | 10.6 | 13.1 | 9.7-17.4 | 11.6 | 10.2 | 7.7-13.2 |
| Leukemias | 23.2 | 12.2 | 10.0-14.7 | 13.0 | 15.4 | 11.8-19.8 | 10.2 | 9.7 | 7.2-12.9 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.
